Helicobacter pyloriSeropositivity and Coronary Heart Disease Incidence
暂无分享,去创建一个
D. Graham | A. Folsom | L. Chambless | P. Sorlie | F. Nieto
[1] M. Law,et al. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study , 1997, BMJ.
[2] I. Fong,et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.
[3] J. Danesh,et al. Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.
[4] G. Porro,et al. Helicobacter pylori infection and coagulation in healthy people , 1997, BMJ.
[5] T. Strandberg,et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population , 1997, BMJ.
[6] A. Folsom,et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity , 1996 .
[7] F. Blasi,et al. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. , 1996, Atherosclerosis.
[8] J. Sanderson,et al. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. , 1996, Heart.
[9] D. Strachan,et al. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. , 1996, Heart.
[10] D. Graham,et al. Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection , 1996, Journal of clinical microbiology.
[11] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[12] S. Pallio,et al. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. , 1996, The new microbiologica.
[13] A. Folsom,et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.
[14] J. Hoekstra,et al. High seroprevalence ofHelicobacter pylori in diabetes mellitus patients , 1996, Digestive Diseases and Sciences.
[15] L. Murray,et al. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. , 1995, British heart journal.
[16] W. Barlow,et al. Robust variance estimation for the case-cohort design. , 1994, Biometrics.
[17] D. Strachan,et al. Fibrinogen: a link between chronic infection and coronary heart disease , 1994, The Lancet.
[18] A. Folsom,et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: The aric study , 1994, Journal of medical virology.
[19] A. Folsom,et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.
[20] C. J. Whitaker,et al. Social and geographical risk factors in Helicobacter pylori infection , 1993, Epidemiology and Infection.
[21] N. Bartoníková,et al. [Helicobacter pylori in patients with diabetes mellitus]. , 1993, Vnitrni lekarstvi.
[22] D. Thomas,et al. Exposure measurement error: influence on exposure-disease. Relationships and methods of correction. , 1993, Annual review of public health.
[23] G. Heller,et al. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy: different findings in males and females. , 1992, Journal of clinical epidemiology.
[24] D. Strachan,et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life , 1992, The Lancet.
[25] A. Folsom,et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.
[26] George Howard,et al. High‐resolution B‐Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC) , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[27] M. Malinow,et al. Homocyst(e)inemia in daily practice: levels in coronary artery disease , 1990 .
[28] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[29] L. Taylor,et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.
[30] D. Graham,et al. A sensitive and specific serologic test for detection of Campylobacter pylori infection. , 1989, Gastroenterology.
[31] L. A. Smolin,et al. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. , 1988, Analytical biochemistry.
[32] J. Altman,et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.
[33] W. Gruber,et al. Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[34] M. Debakey,et al. CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.
[35] J E Frijters,et al. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.
[36] Ronald J. Prineas,et al. The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .
[37] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[38] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[39] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .